Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin-Reference-Cited by-同舟云学术

Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin

Published:2008-12 Issue:6 Volume:180 Page:2379-2383
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sidi Abraham Ami¹,Ohana Patricia²,Benjamin Shalva¹,Shalev Moshe³,Ransom Janet H.⁴,Lamm Donald⁵,Hochberg Avraham²,Leibovitch Ilan³

Affiliation:

1. Department of Urologic Surgery, Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Holon, Israel

2. Department of Biological Chemistry, Institute of Life Sciences, Jerusalem, Israel

3. Department of Urologic Surgery, Meir Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Kfar Saba, Israel

4. Fast-Track Drugs and Biologics L. L. C., North Potomac, Maryland

5. BCG Oncology, Phoenix, Arizona

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Cystectomy for bladder cancer: a contemporary series;Dalbagni;J Urol,2001

3. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

4. Bladder cancer;Montie;J Natl Compr Canc Netw,2006

5. The non-coding RNAs as riboregulators;Erdmann;Nucleic Acids Res,2001

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

2. A simple scalable extracellular vesicle isolation method using polyethylenimine polymers for use in cellular delivery;Extracellular Vesicle;2024-06

3. Innovative therapeutic strategies to overcome radioresistance in breast cancer;Frontiers in Oncology;2024-05-30

4. The Evaluation of the N-cadherin Promoter’s ability to Block EMT by Specific Expression of Diphtheria Toxin in EMT-induced A549 Cell Lines;Iranian Journal of Allergy, Asthma and Immunology;2024-04-14

5. Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing;Hepatology Communications;2024-03-18